Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epigenetics of glioblastoma multiforme: From molecular mechanisms to therapeutic approaches
Md. Sahab Uddin, Abdullah Al Mamun, Badrah S. Alghamdi, et al.
Seminars in Cancer Biology (2020) Vol. 83, pp. 100-120
Closed Access | Times Cited: 139

Showing 1-25 of 139 citing articles:

An update on the molecular biology of glioblastoma, with clinical implications and progress in its treatment
Elena Verdugo, Iker Puerto, Miguel Ángel Medina
Cancer Communications (2022) Vol. 42, Iss. 11, pp. 1083-1111
Open Access | Times Cited: 116
Glioblastoma Therapy: Past, Present and Future
Elena Obrador, Paz Moreno-Murciano, María Oriol‐Caballo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2529-2529
Open Access | Times Cited: 61
Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives
Hao Lin, Chaxian Liu, An-Kang Hu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 60
miRNAs role in glioblastoma pathogenesis and targeted therapy: Signaling pathways interplay
Shereen Saeid Elshaer, Ahmed I. Abulsoud, Doaa Fathi, et al.
Pathology - Research and Practice (2023) Vol. 246, pp. 154511-154511
Closed Access | Times Cited: 56
Emerging role of artificial intelligence in diagnosis, classification and clinical management of glioma
Jiefeng Luo, Mika Pan, Ke Mo, et al.
Seminars in Cancer Biology (2023) Vol. 91, pp. 110-123
Closed Access | Times Cited: 49
Histone H3K9 Lactylation Confers Temozolomide Resistance in Glioblastoma via LUC7L2‐Mediated MLH1 Intron Retention
Yue Qu, Zhao Wang, Yixiong Shen, et al.
Advanced Science (2024) Vol. 11, Iss. 19
Open Access | Times Cited: 35
Flavonoid Rutin Presented Anti-Glioblastoma Activity Related to the Modulation of Onco miRNA-125b Expression and STAT3 Signaling and Impact on Microglia Inflammatory Profile
Irlã Santos Lima, Érica Novaes Soares, Carolina Kymie Vasques Nonaka, et al.
Brain Sciences (2024) Vol. 14, Iss. 1, pp. 90-90
Open Access | Times Cited: 30
Glioblastoma: An Update in Pathology, Molecular Mechanisms and Biomarkers
Zhong Lan, Xin Li, Xiao-Qin Zhang
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 3040-3040
Open Access | Times Cited: 30
Exploring ncRNA-mediated regulation of EGFR signalling in glioblastoma: From mechanisms to therapeutics
Riya Thapa, Muhammad Afzal, Ahsas Goyal, et al.
Life Sciences (2024) Vol. 345, pp. 122613-122613
Closed Access | Times Cited: 25
Principles in the Management of Glioblastoma
Domingos Sanchez Roda, Pedro Veiga, Joana Barbosa Melo, et al.
Genes (2024) Vol. 15, Iss. 4, pp. 501-501
Open Access | Times Cited: 17
Bioengineered protein nanocarrier facilitating siRNA escape from lysosomes for targeted RNAi therapy in glioblastoma
Yiliang Jin, Baoli Zhang, Jianru Li, et al.
Science Advances (2025) Vol. 11, Iss. 8
Closed Access | Times Cited: 3
Impact of epigenetic reprogramming on antitumor immune responses in glioma
Brandon L. McClellan, Santiago Haase, Felipe J. Núñez, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 2
Open Access | Times Cited: 38
Pyroptosis, ferroptosis, and autophagy cross-talk in glioblastoma opens up new avenues for glioblastoma treatment
Sicheng Wan, Guanghui Zhang, Ruochen Liu, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 29
Quercetin induces MGMT+ glioblastoma cells apoptosis via dual inhibition of Wnt3a/β-Catenin and Akt/NF-κB signaling pathways
Wanyu Wang, Xiaopeng Yuan, Jiasheng Mu, et al.
Phytomedicine (2023) Vol. 118, pp. 154933-154933
Closed Access | Times Cited: 27
Cell death pathways: molecular mechanisms and therapeutic targets for cancer
Shaohui Wang, Sa Guo, Jing Guo, et al.
MedComm (2024) Vol. 5, Iss. 9
Open Access | Times Cited: 12
Comprehensive understanding of glioblastoma molecular phenotypes: classification, characteristics, and transition
Can Xu, Pengyu Hou, Xiang Li, et al.
Cancer Biology and Medicine (2024), pp. 1-19
Open Access | Times Cited: 11
FTO Suppresses Proliferation and Induces Apoptosis of T98G Glioblastoma Cells via N6-methyladenosine Modification of GSTO1
Jinjiang Dong, J.P. Mao, Weihua Wu, et al.
Neurochemical Research (2025) Vol. 50, Iss. 2
Closed Access | Times Cited: 1
EZH2 as a new therapeutic target in brain tumors: Molecular landscape, therapeutic targeting and future prospects
Mahshid Deldar Abad Paskeh, Atefeh Mehrabi, Mohammad Gholami, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 146, pp. 112532-112532
Open Access | Times Cited: 45
BRD4: New hope in the battle against glioblastoma
Weichen Duan, Miao Yu, Jiajia Chen
Pharmacological Research (2023) Vol. 191, pp. 106767-106767
Open Access | Times Cited: 18
Glut-3 Gene Knockdown as a Potential Strategy to Overcome Glioblastoma Radioresistance
Gaia Pucci, Luigi Minafra, Valentina Bravatà, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2079-2079
Open Access | Times Cited: 7
Epigenetic regulation of tumor-immune symbiosis in glioma
Yang Liu, Heba Ali, Fatima Khan, et al.
Trends in Molecular Medicine (2024) Vol. 30, Iss. 5, pp. 429-442
Open Access | Times Cited: 6
Polyphenolic molecules targeting STAT3 pathway for the treatment of cancer
Md. Abdul Aziz, Md Shahid Sarwar, Tahmina Akter, et al.
Life Sciences (2021) Vol. 268, pp. 118999-118999
Closed Access | Times Cited: 37
The Impact of Epigenetic Modifications on Adaptive Resistance Evolution in Glioblastoma
Qiong Wu, Anders Berglund, Arnold B. Etame
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 8324-8324
Open Access | Times Cited: 35
Alterations in Molecular Profiles Affecting Glioblastoma Resistance to Radiochemotherapy: Where Does the Good Go?
Juliana Brandstetter Vilar, Markus Christmann, Maja Tomičić
Cancers (2022) Vol. 14, Iss. 10, pp. 2416-2416
Open Access | Times Cited: 24
Epigenetics and Metabolism Reprogramming Interplay into Glioblastoma: Novel Insights on Immunosuppressive Mechanisms
Filippo Torrisi, Simona D’Aprile, Simona Denaro, et al.
Antioxidants (2023) Vol. 12, Iss. 2, pp. 220-220
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top